Report Detail
Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3260824 |
- 04 April, 2019 |
- Global |
- 99 Pages |
- QYResearch |
- Other
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
In 2018, the global mRNA Cancer Vaccines and Therapeutics market size was 110 million US$ and it is expected to reach 610 million US$ by the end of 2025, with a CAGR of 24.1% during 2019-2025.
This report focuses on the global mRNA Cancer Vaccines and Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the mRNA Cancer Vaccines and Therapeutics development in United States, Europe and China.
The key players covered in this study
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market segment by Type, the product can be split into
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Market segment by Application, split into
Infectious Disease
Cancer
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global mRNA Cancer Vaccines and Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the mRNA Cancer Vaccines and Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of mRNA Cancer Vaccines and Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Adeno Carcinomas
- 1.4.3 Mucinous Carcinomas
- 1.4.4 Adenosquamous Carcinomas
- 1.5 Market by Application
- 1.5.1 Global mRNA Cancer Vaccines and Therapeutics Market Share by Application (2014-2025)
- 1.5.2 Infectious Disease
- 1.5.3 Cancer
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 mRNA Cancer Vaccines and Therapeutics Market Size
- 2.2 mRNA Cancer Vaccines and Therapeutics Growth Trends by Regions
- 2.2.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions (2014-2025)
- 2.2.2 mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 mRNA Cancer Vaccines and Therapeutics Market Size by Manufacturers
- 3.1.1 Global mRNA Cancer Vaccines and Therapeutics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
- 3.3 Key Players mRNA Cancer Vaccines and Therapeutics Product/Solution/Service
- 3.4 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2014-2019)
- 4.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2014-2019)
5 United States
- 5.1 United States mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
- 5.2 mRNA Cancer Vaccines and Therapeutics Key Players in United States
- 5.3 United States mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 5.4 United States mRNA Cancer Vaccines and Therapeutics Market Size by Application
6 Europe
- 6.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
- 6.2 mRNA Cancer Vaccines and Therapeutics Key Players in Europe
- 6.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 6.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application
7 China
- 7.1 China mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
- 7.2 mRNA Cancer Vaccines and Therapeutics Key Players in China
- 7.3 China mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 7.4 China mRNA Cancer Vaccines and Therapeutics Market Size by Application
8 Japan
- 8.1 Japan mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
- 8.2 mRNA Cancer Vaccines and Therapeutics Key Players in Japan
- 8.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 8.4 Japan mRNA Cancer Vaccines and Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
- 9.2 mRNA Cancer Vaccines and Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 9.4 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size by Application
10 India
- 10.1 India mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
- 10.2 mRNA Cancer Vaccines and Therapeutics Key Players in India
- 10.3 India mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 10.4 India mRNA Cancer Vaccines and Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America mRNA Cancer Vaccines and Therapeutics Market Size (2014-2019)
- 11.2 mRNA Cancer Vaccines and Therapeutics Key Players in Central & South America
- 11.3 Central & South America mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 11.4 Central & South America mRNA Cancer Vaccines and Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 Moderna Therapeutics
- 12.1.1 Moderna Therapeutics Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 mRNA Cancer Vaccines and Therapeutics Introduction
- 12.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
- 12.1.5 Moderna Therapeutics Recent Development
- 12.2 CureVac
- 12.2.1 CureVac Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 mRNA Cancer Vaccines and Therapeutics Introduction
- 12.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
- 12.2.5 CureVac Recent Development
- 12.3 Translate Bio
- 12.3.1 Translate Bio Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 mRNA Cancer Vaccines and Therapeutics Introduction
- 12.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
- 12.3.5 Translate Bio Recent Development
- 12.4 BioNTech
- 12.4.1 BioNTech Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 mRNA Cancer Vaccines and Therapeutics Introduction
- 12.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
- 12.4.5 BioNTech Recent Development
- 12.5 Sangamo Therapeutics
- 12.5.1 Sangamo Therapeutics Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 mRNA Cancer Vaccines and Therapeutics Introduction
- 12.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
- 12.5.5 Sangamo Therapeutics Recent Development
- 12.6 Argos Therapeutics
- 12.6.1 Argos Therapeutics Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 mRNA Cancer Vaccines and Therapeutics Introduction
- 12.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
- 12.6.5 Argos Therapeutics Recent Development
- 12.7 In-Cell-Art
- 12.7.1 In-Cell-Art Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 mRNA Cancer Vaccines and Therapeutics Introduction
- 12.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
- 12.7.5 In-Cell-Art Recent Development
- 12.8 eTheRNA
- 12.8.1 eTheRNA Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 mRNA Cancer Vaccines and Therapeutics Introduction
- 12.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
- 12.8.5 eTheRNA Recent Development
- 12.9 Ethris
- 12.9.1 Ethris Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 mRNA Cancer Vaccines and Therapeutics Introduction
- 12.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
- 12.9.5 Ethris Recent Development
- 12.10 Tiba Biotechnology
- 12.10.1 Tiba Biotechnology Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 mRNA Cancer Vaccines and Therapeutics Introduction
- 12.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2014-2019)
- 12.10.5 Tiba Biotechnology Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on mRNA Cancer Vaccines and Therapeutics . Industry analysis & Market Report on mRNA Cancer Vaccines and Therapeutics is a syndicated market report, published as Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of mRNA Cancer Vaccines and Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
